Hypoxia Services For Medical Management
-
Manufactured by Akebia Therapeutics, Inc.based in USA
Tenacity: At Akebia, we are inspired to think boldly and move bold thinking into action. We leverage our scientific expertise and this innovative thinking to develop clinical advances in areas that are important to people living with kidney disease. We thrive as collaborators because we believe that we can go further together. We work with partners across the globe to pioneer and grow new areas ...
-
Manufactured by SomaGenics, Inc.based in USA
SomaGenics’ wound healing program addresses the pressing unmet medical need for the effective treatment of chronic wounds, most commonly, diabetic foot ulcers (DFUs). Close to 25% of patients with diabetes develop foot ulcers with nearly 12% leading to amputation. Current standard of care therapy is not effective and treatment usually requires costly extended hospital stays. There is an ...
-
Manufactured by Angionica Ltd.based in POLAND
The first test implemented by Angionica is the FMSF–PORH test (Flow Mediated Skin Fluorescence–Post-Occlusive Reactive Hyperemia), which is used to assess microvascular circulation (vascular endothelial function) based on circulatory stimulation in response to induced reactive hyperemia (PORH). The test makes it possible to assess levels of both contraction and vasodilation and to ...
-
based in GERMANY
Ronopterin – treatment to reduce retinal edema and improve patient outcomes. Adequate, pharmacologic control of retinal edema progression in diabetes is still insufficient. More than 50% of patients suffer from impairing side effects and require repetitive injections into the ...
-
Manufactured by Angionica Ltd.based in POLAND
The FMSF-HS test allows assessment of microcirculatory status based on analysis of baseline oscillations and the reperfusion signal, showing changes in NADH fluorescence due to induced reactive hyperemia ...
-
Manufactured by Senzime AB Uppsalabased in SWEDEN
Residual Neuromuscular Blockade – the need for quantitative monitoring. Residual neuromuscular block is perhaps most accurately defined as the presence of signs or symptoms of muscle weakness in the postoperative period after the intraoperative administration of an NMBD. Muscle relaxants have revolutionized anesthesiology, and are routinely used to: improve intubating conditions, decrease ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you